Forest Hills, NY, United States of America

Yum K Yip


Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1984-1990

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yum K Yip: Innovator in Gamma-Interferon Research

Introduction

Yum K Yip is a notable inventor based in Forest Hills, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of gamma-interferon research. With a total of 3 patents, his work has had a profound impact on antiviral and cytolytic activities.

Latest Patents

Yip's latest patents include a novel polypeptide having gamma-interferon activity. This invention provides a peptide with an amino acid sequence of less than about 100 amino acids, which is immunochemically reactive with an antibody directed against human gamma-interferon. It displays gamma-interferon antiviral and cytolytic activities. Another significant patent is for a human gamma interferon polypeptide having glutamine as the ninth amino acid. This patent discloses a novel DNA that shows complementarity to human interferon-gamma mRNA, along with a recombinant plasmid containing the DNA and a microorganism that includes the recombinant plasmid. It also outlines a method for producing a polypeptide with human interferon-gamma activity using the microorganism.

Career Highlights

Throughout his career, Yum K Yip has worked with prestigious institutions, including New York University and the Japanese Foundation for Cancer Research. His research has contributed to advancements in understanding and utilizing gamma-interferon in medical applications.

Collaborations

Yip has collaborated with esteemed colleagues such as Jan T Vilcek and Tadatsugu Taniguchi, further enhancing the impact of his research in the scientific community.

Conclusion

Yum K Yip's innovative work in gamma-interferon research has led to significant advancements in biotechnology. His patents and collaborations reflect his dedication to improving antiviral therapies and understanding immune responses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…